Xi Tang

Title: Xi Tang - Innovator in Cell Therapy

Introduction

Xi Tang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cell therapy, particularly in the development of innovative treatments for malignant tumors. His work focuses on enhancing the efficacy of T cell therapies through advanced genetic modifications.

Latest Patents

Xi Tang holds a patent for an "Antibody-modified chimeric antigen receptor modified T cell and uses thereof." This invention relates to a T cell that expresses an antibody or comprises the coding sequence of the antibody or an expression vector thereof. The antibody includes an optional signal peptide, an antigen binding sequence, and a mutant type Fc segment. The mutant type Fc segment is characterized by mutations at the 17th and 79th amino acid residues of the IgG4 Fc segment, specifically altered to E and Q, respectively. Notably, the T cell is a CAR-T cell, and the invention further explores its application in treating malignant tumors. Xi Tang has 1 patent to his name.

Career Highlights

Xi Tang is associated with Shanghai Cell Therapy Group Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing evolution of cell-based therapies, particularly in oncology.

Collaborations

Xi Tang collaborates with notable colleagues, including Qijun Qian and Huajun Jin, who contribute to his research endeavors.

Conclusion

Xi Tang's innovative work in the field of cell therapy exemplifies the potential of genetic engineering in treating complex diseases. His contributions are paving the way for future advancements in cancer treatment.